Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.

MRÁZ, Marek. Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels. In ESH Translational Research E-Conference. 2021.

Basic information

Original name

Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.

Authors

MRÁZ, Marek

Edition

ESH Translational Research E-Conference, 2021

---

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology